Stay updated on Lanadelumab for Pediatric HAE Attacks Clinical Trial
Sign up to get notified when there's something new on the Lanadelumab for Pediatric HAE Attacks Clinical Trial page.

Latest updates to the Lanadelumab for Pediatric HAE Attacks Clinical Trial page
- CheckyesterdayChange DetectedThe Record History page now includes a new revision entry, v3.6.5. The previous v3.6.4 entry has been removed, reflecting a site release update.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedA new revision entry (v3.6.4) appears in the study record history, updating the version from v3.6.3. This reflects an administrative update to the record’s revision metadata.SummaryDifference0.1%

- Check23 days agoNo Change Detected
- Check37 days agoChange DetectedA new revision, v3.6.3, was added, replacing the previous v3.6.2. This reflects an update to the page's record history.SummaryDifference0.1%

- Check44 days agoChange DetectedA new revision label v3.6.2 has been added to the record history, replacing the older v3.6.0 entry. This reflects an updated site release in the page's version history.SummaryDifference0.1%

- Check58 days agoChange DetectedThe history now indicates recruitment has closed (no longer looking for participants). A new revision tag v3.6.0 was added and the previous revision tag v3.5.5 was removed.SummaryDifference0.4%

- Check65 days agoChange DetectedThe history now lists Revision: v3.5.5, replacing the previous v3.5.4. This marks a new revision of the page's documentation within ClinicalTrials.gov.SummaryDifference0.1%

Stay in the know with updates to Lanadelumab for Pediatric HAE Attacks Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lanadelumab for Pediatric HAE Attacks Clinical Trial page.